We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

USEA:NASDAQUnited Maritime Corporation Analysis

Data as of 2026-09-01 - not real-time

$2.76

Latest Price

8/10Risk

Risk Level: High

Executive Summary

At $2.76, United Maritime Corporation shows a bullish moving-average alignment, with shorter averages sitting above longer ones. It has gained 12.7% over the past 30 days. RSI sits at 57.0, which reads as neutral, and MACD momentum is bullish. Recent trading has carved out support near $2.56 and resistance around $2.91.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 44.9% above where the shares trade now. Revenue is contracting at 19.9% on a -4.9% profit margin. The 14.49% dividend yield looks covered by current payout levels.
Risk scores 8 out of 10, which is high for this asset class. With 30-day volatility of 36.9%, a beta of 1.05 and a maximum drawdown of 24.0%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Timeframes disagree: the short-term read is buy while the long-term read is hold, conviction 1 out of 10.

Top Market Events

Strategic Fleet Repositioning into Capesize Vessels Declares Quarterly Cash Dividend of $0.Strategic Fleet Repositioning into Capesize VesselsSeeking Alpha1monUnited Maritime Corporation USEA Q2 2026 Earnings Call TranscriptThank you for standing by, ladies and...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 2.18
  • MACD momentum is positive

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 2.18
  • Analyst targets imply +44.9% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • Negative profit margin of -4.9%
  • Analyst targets imply +44.9% versus the current price
  • Negative return on equity of -3.0%

Key Metrics & Analysis

Financial Health

Revenue Growth-19.90%
Profit Margin-4.89%
P/E Ratio-276.0
ROE-2.97%
ROA1.23%
Debt/Equity176.88
P/B Ratio0.4
Op. Cash Flow$6.2M
Free Cash Flow$-4358625
Industry P/E29.0

Technical Analysis

TrendBullish
RSI57.0
Support$2.56
Resistance$2.91
MA 20$2.72
MA 50$2.66
MA 200$2.18
MACDBullish
VolumeDecreasing
Fear & Greed Index94.39

Valuation

Target Price$4.00
Upside/Downside44.93%
GradeUndervalued
TypeValue
Dividend Yield14.49%

Risk Assessment

Beta1.05
Volatility36.90%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.